Americans pay significantly higher prices for prescription drugs compared to other high-income industrialized countries, sometimes two to four times as much. President Biden’s claim that prescriptions can be filled for 40% to 60% less in other countries is mostly accurate for comparable nations. Factors like country-specific pricing, rebates, and discounts can make price comparisons challenging. While the U.S. pays less for unbranded generic drugs, the prices for brand-name drugs remain high. The U.S. lacks comprehensive price negotiation mechanisms used by other countries, leading to higher drug costs. Biden’s statement is mostly true but needs clarification and context.
Source link